Skip to main content

Genitourinary Cancer Specialty Channel

Featured Article
The automated Bone Scan Index shows strong prognostic utility as an objective imaging biomarker for patients with metastatic castration-resistant…
The US Food and Drug Administration approved a new combination to treat patients with metastatic castration-resistant prostate cancer.
The FDA released information about decreased survival rates associated with the use of two different drugs.
Expert Insights
Hereditary kidney cancer syndromes include von Hippel-Lindau disease, hereditary leiomyomatosis and renal cell cancer, Birt-Hogg-Dubé syndrome, and…
Expert-reviewed information summary about the treatment of gallbladder cancer.
Information about extracranial GCTs including symptoms, diagnosis, histology, tumor biology, classification, prognosis, staging, and treatment.
Information about bladder cancer including symptoms, diagnosis, histology, tumor biology, classification, prognosis, staging, and treatment.
Interactive Features
According to a recent study, what type of radiotherapy was proven safe and effective for patients with prostate cancer?
Do you know the new treatment that shows significant improvement in metastasis-free survival and time to symptomatic progression among men with non-…
A recent study suggests that a drug combination showed significantly higher overall survival and objective response rates in patients with renal-cell…